Why the study?
Does the location of myocardial hypertrophy influence right ventricular diastolic function in patients with non-obstructive hypertrophic cardiomyopathy?
Does the location of myocardial hypertrophy influence right ventricular diastolic function in patients with non-obstructive hypertrophic cardiomyopathy?
Right ventricular diastolic function is impaired in patients with asymmetric septal hypertrophy but not in those with apical hypertrophy, suggesting that the location of left ventricular hypertrophy affects right ventricular filling.
Answers are grounded in this paper and cite their sources.
RV diastolic impairment may vary by LV hypertrophy site in non-obstructive HCM; hypothesis-generating and requires prospective validation.
We examined whether differences in the location of myocardial hypertrophy influence the right ventricular diastolic function in patients with non-obstructive hypertrophic cardiomyopathy using cineangiography. Biplane right ventriculography was performed in 34 subjects (normal = 14, asymmetric septal hypertrophy = 9, apical hypertrophy = 11) during cardiac catheterization. In patients with asymmetric septal hypertrophy, compared with apical hypertrophy and normal groups, the indices of the right ventricular diastolic function including right ventricular peak filling rate and filling fraction of rapid filling phase were lower and the time to peak filling rate was prolonged. But in patients with apical hypertrophy, these indices were not significantly different compared with normal. There were no differences in right ventricular ejection fraction and cardiac index among the three groups. These data suggest that the location of the myocardial hypertrophy of the left ventricle is a significant factor affecting the right ventricular diastolic filling in non-obstructive hypertrophic cardiomyopathy.
No takes yet. Share an insight, caveat, or question.
Komaki et al. (2003) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: